Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease... https://t.co/q1T7BTFBF6 https://t.co/1LP9Dav6gO
27 followers
397 followers
RT @Myeloma_Doc: #Kyprolis pharmacokinetics & saftey study in #myeloma pts w/ renal disease suggests no dose adjustment needed: https://t.c…
698 followers
RT @Myeloma_Doc: #Kyprolis pharmacokinetics & saftey study in #myeloma pts w/ renal disease suggests no dose adjustment needed: https://t.c…
14,844 followers
#Kyprolis pharmacokinetics & saftey study in #myeloma pts w/ renal disease suggests no dose adjustment needed: https://t.co/WLWVGD92UG. https://t.co/Mr3LWCoLg3